HEИндивидуална стипендия2026–2028

X-CITE · Uncovering the Role of X Chromsome Inactivation Escapees in T Cell Function

„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“

Период
2026-09-01 → 2028-08-31
Финансиране от ЕС
232 916 €
Участници
1
Схема
HORIZON-TMA-MSCA-PF-EF

Линиите свързват координатора с партньорите.

Накратко на български

Гените от X-хромозомата, които остават активни и при жените, влияят върху работата на Т-клетките в имунната система. Разбирането на тези полови разлики помага за подобряване на ефективността на имунотерапията при рак.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Цел на проекта

Sex differences play a significant role in immune function, with women generally mounting stronger immune responses than men. A key factor behind these differences is the X chromosome, which contains many genes that are important for immune function. In females, who have two X chromosomes, one of the X chromosomes is usually inactivated in each cell to prevent an overdose of X-linked gene expression. This process is known as X-chromosome inactivation (XCI). However, some genes can escape this inactivation and are expressed from both X chromosomes. These escapee genes are often expressed at higher levels in females than in males, who only have one X chromosome. The X-CITE (X-Chromosome Inactivation and T cell Escape) project aims to elucidate the molecular mechanisms by which these XCI escapee genes influence T cell responses. Understanding these mechanisms is crucial, as T cells are central to the success of cancer immunotherapy, where sex-based differences in T cell function may impact treatment outcomes. By exploring the sex-biased expression of XCI escapee genes, this project will advance our understanding of sex differences in immune responses and provide new insights into how T cells can be manipulated to improve the efficacy of cancer immunotherapy. The research will be conducted at the Landsteiner Laboratory Amsterdam UMC-Sanquin (The Netherlands), under the supervision of Dr. Monika Wolkers, whose lab specializes in T cell biology and the enhancement of T cell functions in immunotherapy settings.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз